# Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

> **NCT00035048** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 540 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** aprepitant
- **DRUG:** Comparator: placebo (unspecified)

## Key facts

- **NCT ID:** NCT00035048
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11-21
- **Primary completion:** 2003-12-29
- **Final completion:** 2003-12-31
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035048, "Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00035048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*